Search > Epilepsy
200 Participants NeededMy employer runs this trial

AI-Based Mobile Intervention for Epilepsy

Recruiting at 1 trial location
MT
AF
Overseen ByAmoy Fraser, PhD, CCRP, PMP
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Central Florida
Must be taking: Anti-seizure medicines
Disqualifiers: No mobile device, Severe intellectual disability, others
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA.

Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.

Who Is on the Research Team?

MT

Michelle Tall, PhD, RN, FAES

Principal Investigator

University of Central Florida

Are You a Good Fit for This Trial?

Inclusion Criteria

I have been diagnosed with epilepsy.
Able to read, speak, and write in English
Resides in Florida
See 5 more

Exclusion Criteria

I am an adult who cannot give consent for myself.
Pregnant women (excluded because pregnancy is not relevant to the study focus)
Reside in an in-patient setting
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use either the AI-personalized or standard version of the Medilepsy® app to improve medication adherence and transition readiness

3-6 months

Follow-up

Participants are monitored for usability and effectiveness of the Medilepsy® app after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Medilepsy® Chatbot AI-Enhanced

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Medilepsy® Chatbot AI-EnhancedExperimental Treatment1 Intervention
Group II: Medilepsy® Chatbot StandardActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Central Florida

Lead Sponsor

Trials
101
Recruited
1,191,000+

Orlando Health Arnold Palmer Hospital

Collaborator

American Epilepsy Society

Collaborator

Trials
8
Recruited
250+

Orlando Regional Medical Center

Collaborator

Trials
6
Recruited
1,600+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.